Oncology Small Molecule Drugs Market Forecast to 2027 - COVID-19 Impact and Global Analysis By Drug Class (Chemotherapy Drugs, Immunomodulating Drugs, Hormonal Therapy, Targeted Therapy Drugs); Indication Type (Breast Cancer, Prostate Cancer, Multiple Myeloma, Melanoma, Lymphoma, Leukemia, Non-small Cell Lung Cancer (NSCLC), Renal Cell Carcinoma, Others); Route of Administration (Oral, Injectable); Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Specialty Clinics, Online Pharmacies)

Report Code: TIPRE00021902 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming

Covid
Assesing the covid-19 impact?
Get the Latest COVID-19 Analysis on this market
Get Free Sample PDF
Happy to join you in your fight against the COVID-19 economic pandemic!
MARKET INTRODUCTION

Small-molecule drugs are compounds with low molecular weight and possess the capability of modulating biochemical processes in order to diagnose, treat, or prevent diseases. These small molecule drugs inhibit tumor cell growth and hence are potential cancer treatment drugs.

MARKET DYNAMICS

The oncology small molecule drugs market is expected to grow owing to growing prevalence of cancer, and rising research and development activities for cancer drugs. Moreover, growing pharmaceutical industry may create growth opportunities for the market.

MARKET SCOPE

The "Oncology Small Molecule Drugs Market Analysis to 2027" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of oncology small molecule drugs market with detailed market segmentation by drug class, indication type, route of administration and distribution channel. The oncology small molecule drugs market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in oncology small molecule drugs market and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The oncology small molecule drugs market is segmented on the basis of drug class, indication type, route of administration and distribution channel. Based on drug class, the market is segmented as chemotherapy drugs, immunomodulating drugs, hormonal therapy, and targeted therapy drugs. Based on indication type, the market is segmented as breast cancer, prostate cancer, multiple myeloma, melanoma, lymphoma, leukemia, non-small cell lung cancer (NSCLC), renal cell carcinoma, others. By route of administration the market is segmented into oral and injectable. The End User segment is segmented into hospital pharmacies, retail pharmacies, specialty clinics, and online pharmacies.

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the oncology small molecule drugs market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The oncology small molecule drugs market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting oncology small molecule drugs market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the oncology small molecule drugs market in these regions.



Get more information on this report :

MARKET PLAYERS


The report covers key developments in the oncology small molecule drugs market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from oncology small molecule drugs market are anticipated to have lucrative growth opportunities in the future with the rising demand for oncology small molecule drugs in the global market. Below mentioned is the list of few companies engaged in the oncology small molecule drugs market.

The report also includes the profiles of key players in oncology small molecule drugs market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

  •   Johnson & Johnson
  •   Boehringer Ingelheim
  •   Pfizer
  •   Merck
  •   GlaxoSmithkline
  •   Gilead Sciences
  •   Teva Pharmaceutical
  •   Allergan
  •   Bristol- Myers Squibb
  •   AstraZeneca.

The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.


Get more information on this report :

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Oncology Small Molecule Drugs Market - By Drug Class
1.3.2 Oncology Small Molecule Drugs Market - By Indication Type
1.3.3 Oncology Small Molecule Drugs Market - By Route of Administration
1.3.4 Oncology Small Molecule Drugs Market - By Distribution Channel
1.3.5 Oncology Small Molecule Drugs Market - By Region
1.3.5.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. ONCOLOGY SMALL MOLECULE DRUGS MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. ONCOLOGY SMALL MOLECULE DRUGS MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. ONCOLOGY SMALL MOLECULE DRUGS MARKET - GLOBAL MARKET ANALYSIS
6.1. ONCOLOGY SMALL MOLECULE DRUGS - GLOBAL MARKET OVERVIEW
6.2. ONCOLOGY SMALL MOLECULE DRUGS - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING
7. ONCOLOGY SMALL MOLECULE DRUGS MARKET - REVENUE AND FORECASTS TO 2028 - DRUG CLASS
7.1. OVERVIEW
7.2. DRUG CLASS MARKET FORECASTS AND ANALYSIS
7.3. CHEMOTHERAPY DRUGS
7.3.1. Overview
7.3.2. Chemotherapy Drugs Market Forecast and Analysis
7.3.3. Alkylating Agents Market
7.3.3.1. Overview
7.3.3.2. Alkylating Agents Market Forecast and Analysis
7.3.4. Antimetabolites Market
7.3.4.1. Overview
7.3.4.2. Antimetabolites Market Forecast and Analysis
7.3.5. Other Drugs Market
7.3.5.1. Overview
7.3.5.2. Other Drugs Market Forecast and Analysis
7.4. IMMUNOMODULATING DRUGS
7.4.1. Overview
7.4.2. Immunomodulating Drugs Market Forecast and Analysis
7.5. HORMONAL THERAPY
7.5.1. Overview
7.5.2. Hormonal Therapy Market Forecast and Analysis
7.6. TARGETED THERAPY DRUGS
7.6.1. Overview
7.6.2. Targeted Therapy Drugs Market Forecast and Analysis
7.6.3. Proteasome Inhibitors Market
7.6.3.1. Overview
7.6.3.2. Proteasome Inhibitors Market Forecast and Analysis
7.6.4. Tyrosine Kinase Inhibitors Market
7.6.4.1. Overview
7.6.4.2. Tyrosine Kinase Inhibitors Market Forecast and Analysis
7.6.5. mTOR Inhibitors Market
7.6.5.1. Overview
7.6.5.2. mTOR Inhibitors Market Forecast and Analysis
7.6.6. Others Market
7.6.6.1. Overview
7.6.6.2. Others Market Forecast and Analysis
8. ONCOLOGY SMALL MOLECULE DRUGS MARKET - REVENUE AND FORECASTS TO 2028 - INDICATION TYPE
8.1. OVERVIEW
8.2. INDICATION TYPE MARKET FORECASTS AND ANALYSIS
8.3. BREAST CANCER
8.3.1. Overview
8.3.2. Breast Cancer Market Forecast and Analysis
8.4. PROSTATE CANCER
8.4.1. Overview
8.4.2. Prostate Cancer Market Forecast and Analysis
8.5. MULTIPLE MYELOMA
8.5.1. Overview
8.5.2. Multiple Myeloma Market Forecast and Analysis
8.6. MELANOMA
8.6.1. Overview
8.6.2. Melanoma Market Forecast and Analysis
8.7. LYMPHOMA
8.7.1. Overview
8.7.2. Lymphoma Market Forecast and Analysis
8.8. LEUKEMIA
8.8.1. Overview
8.8.2. Leukemia Market Forecast and Analysis
8.9. NON-SMALL CELL LUNG CANCER (NSCLC)
8.9.1. Overview
8.9.2. Non-small Cell Lung Cancer (NSCLC) Market Forecast and Analysis
8.10. RENAL CELL CARCINOMA
8.10.1. Overview
8.10.2. Renal Cell Carcinoma Market Forecast and Analysis
8.11. OTHERS
8.11.1. Overview
8.11.2. Others Market Forecast and Analysis
9. ONCOLOGY SMALL MOLECULE DRUGS MARKET - REVENUE AND FORECASTS TO 2028 - ROUTE OF ADMINISTRATION
9.1. OVERVIEW
9.2. ROUTE OF ADMINISTRATION MARKET FORECASTS AND ANALYSIS
9.3. ORAL
9.3.1. Overview
9.3.2. Oral Market Forecast and Analysis
9.4. INJECTABLE
9.4.1. Overview
9.4.2. Injectable Market Forecast and Analysis
10. ONCOLOGY SMALL MOLECULE DRUGS MARKET - REVENUE AND FORECASTS TO 2028 - DISTRIBUTION CHANNEL
10.1. OVERVIEW
10.2. DISTRIBUTION CHANNEL MARKET FORECASTS AND ANALYSIS
10.3. HOSPITAL PHARMACIES
10.3.1. Overview
10.3.2. Hospital Pharmacies Market Forecast and Analysis
10.4. RETAIL PHARMACIES
10.4.1. Overview
10.4.2. Retail Pharmacies Market Forecast and Analysis
10.5. SPECIALTY CLINICS
10.5.1. Overview
10.5.2. Specialty Clinics Market Forecast and Analysis
10.6. ONLINE PHARMACIES
10.6.1. Overview
10.6.2. Online Pharmacies Market Forecast and Analysis
11. ONCOLOGY SMALL MOLECULE DRUGS MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
11.1. NORTH AMERICA
11.1.1 North America Oncology Small Molecule Drugs Market Overview
11.1.2 North America Oncology Small Molecule Drugs Market Forecasts and Analysis
11.1.3 North America Oncology Small Molecule Drugs Market Forecasts and Analysis - By Drug Class
11.1.4 North America Oncology Small Molecule Drugs Market Forecasts and Analysis - By Indication Type
11.1.5 North America Oncology Small Molecule Drugs Market Forecasts and Analysis - By Route of Administration
11.1.6 North America Oncology Small Molecule Drugs Market Forecasts and Analysis - By Distribution Channel
11.1.7 North America Oncology Small Molecule Drugs Market Forecasts and Analysis - By Countries
11.1.7.1 United States Oncology Small Molecule Drugs Market
11.1.7.1.1 United States Oncology Small Molecule Drugs Market by Drug Class
11.1.7.1.2 United States Oncology Small Molecule Drugs Market by Indication Type
11.1.7.1.3 United States Oncology Small Molecule Drugs Market by Route of Administration
11.1.7.1.4 United States Oncology Small Molecule Drugs Market by Distribution Channel
11.1.7.2 Canada Oncology Small Molecule Drugs Market
11.1.7.2.1 Canada Oncology Small Molecule Drugs Market by Drug Class
11.1.7.2.2 Canada Oncology Small Molecule Drugs Market by Indication Type
11.1.7.2.3 Canada Oncology Small Molecule Drugs Market by Route of Administration
11.1.7.2.4 Canada Oncology Small Molecule Drugs Market by Distribution Channel
11.1.7.3 Mexico Oncology Small Molecule Drugs Market
11.1.7.3.1 Mexico Oncology Small Molecule Drugs Market by Drug Class
11.1.7.3.2 Mexico Oncology Small Molecule Drugs Market by Indication Type
11.1.7.3.3 Mexico Oncology Small Molecule Drugs Market by Route of Administration
11.1.7.3.4 Mexico Oncology Small Molecule Drugs Market by Distribution Channel
11.2. EUROPE
11.2.1 Europe Oncology Small Molecule Drugs Market Overview
11.2.2 Europe Oncology Small Molecule Drugs Market Forecasts and Analysis
11.2.3 Europe Oncology Small Molecule Drugs Market Forecasts and Analysis - By Drug Class
11.2.4 Europe Oncology Small Molecule Drugs Market Forecasts and Analysis - By Indication Type
11.2.5 Europe Oncology Small Molecule Drugs Market Forecasts and Analysis - By Route of Administration
11.2.6 Europe Oncology Small Molecule Drugs Market Forecasts and Analysis - By Distribution Channel
11.2.7 Europe Oncology Small Molecule Drugs Market Forecasts and Analysis - By Countries
11.2.7.1 Germany Oncology Small Molecule Drugs Market
11.2.7.1.1 Germany Oncology Small Molecule Drugs Market by Drug Class
11.2.7.1.2 Germany Oncology Small Molecule Drugs Market by Indication Type
11.2.7.1.3 Germany Oncology Small Molecule Drugs Market by Route of Administration
11.2.7.1.4 Germany Oncology Small Molecule Drugs Market by Distribution Channel
11.2.7.2 France Oncology Small Molecule Drugs Market
11.2.7.2.1 France Oncology Small Molecule Drugs Market by Drug Class
11.2.7.2.2 France Oncology Small Molecule Drugs Market by Indication Type
11.2.7.2.3 France Oncology Small Molecule Drugs Market by Route of Administration
11.2.7.2.4 France Oncology Small Molecule Drugs Market by Distribution Channel
11.2.7.3 Italy Oncology Small Molecule Drugs Market
11.2.7.3.1 Italy Oncology Small Molecule Drugs Market by Drug Class
11.2.7.3.2 Italy Oncology Small Molecule Drugs Market by Indication Type
11.2.7.3.3 Italy Oncology Small Molecule Drugs Market by Route of Administration
11.2.7.3.4 Italy Oncology Small Molecule Drugs Market by Distribution Channel
11.2.7.4 Spain Oncology Small Molecule Drugs Market
11.2.7.4.1 Spain Oncology Small Molecule Drugs Market by Drug Class
11.2.7.4.2 Spain Oncology Small Molecule Drugs Market by Indication Type
11.2.7.4.3 Spain Oncology Small Molecule Drugs Market by Route of Administration
11.2.7.4.4 Spain Oncology Small Molecule Drugs Market by Distribution Channel
11.2.7.5 United Kingdom Oncology Small Molecule Drugs Market
11.2.7.5.1 United Kingdom Oncology Small Molecule Drugs Market by Drug Class
11.2.7.5.2 United Kingdom Oncology Small Molecule Drugs Market by Indication Type
11.2.7.5.3 United Kingdom Oncology Small Molecule Drugs Market by Route of Administration
11.2.7.5.4 United Kingdom Oncology Small Molecule Drugs Market by Distribution Channel
11.2.7.6 Rest of Europe Oncology Small Molecule Drugs Market
11.2.7.6.1 Rest of Europe Oncology Small Molecule Drugs Market by Drug Class
11.2.7.6.2 Rest of Europe Oncology Small Molecule Drugs Market by Indication Type
11.2.7.6.3 Rest of Europe Oncology Small Molecule Drugs Market by Route of Administration
11.2.7.6.4 Rest of Europe Oncology Small Molecule Drugs Market by Distribution Channel
11.3. ASIA-PACIFIC
11.3.1 Asia-Pacific Oncology Small Molecule Drugs Market Overview
11.3.2 Asia-Pacific Oncology Small Molecule Drugs Market Forecasts and Analysis
11.3.3 Asia-Pacific Oncology Small Molecule Drugs Market Forecasts and Analysis - By Drug Class
11.3.4 Asia-Pacific Oncology Small Molecule Drugs Market Forecasts and Analysis - By Indication Type
11.3.5 Asia-Pacific Oncology Small Molecule Drugs Market Forecasts and Analysis - By Route of Administration
11.3.6 Asia-Pacific Oncology Small Molecule Drugs Market Forecasts and Analysis - By Distribution Channel
11.3.7 Asia-Pacific Oncology Small Molecule Drugs Market Forecasts and Analysis - By Countries
11.3.7.1 Australia Oncology Small Molecule Drugs Market
11.3.7.1.1 Australia Oncology Small Molecule Drugs Market by Drug Class
11.3.7.1.2 Australia Oncology Small Molecule Drugs Market by Indication Type
11.3.7.1.3 Australia Oncology Small Molecule Drugs Market by Route of Administration
11.3.7.1.4 Australia Oncology Small Molecule Drugs Market by Distribution Channel
11.3.7.2 China Oncology Small Molecule Drugs Market
11.3.7.2.1 China Oncology Small Molecule Drugs Market by Drug Class
11.3.7.2.2 China Oncology Small Molecule Drugs Market by Indication Type
11.3.7.2.3 China Oncology Small Molecule Drugs Market by Route of Administration
11.3.7.2.4 China Oncology Small Molecule Drugs Market by Distribution Channel
11.3.7.3 India Oncology Small Molecule Drugs Market
11.3.7.3.1 India Oncology Small Molecule Drugs Market by Drug Class
11.3.7.3.2 India Oncology Small Molecule Drugs Market by Indication Type
11.3.7.3.3 India Oncology Small Molecule Drugs Market by Route of Administration
11.3.7.3.4 India Oncology Small Molecule Drugs Market by Distribution Channel
11.3.7.4 Japan Oncology Small Molecule Drugs Market
11.3.7.4.1 Japan Oncology Small Molecule Drugs Market by Drug Class
11.3.7.4.2 Japan Oncology Small Molecule Drugs Market by Indication Type
11.3.7.4.3 Japan Oncology Small Molecule Drugs Market by Route of Administration
11.3.7.4.4 Japan Oncology Small Molecule Drugs Market by Distribution Channel
11.3.7.5 South Korea Oncology Small Molecule Drugs Market
11.3.7.5.1 South Korea Oncology Small Molecule Drugs Market by Drug Class
11.3.7.5.2 South Korea Oncology Small Molecule Drugs Market by Indication Type
11.3.7.5.3 South Korea Oncology Small Molecule Drugs Market by Route of Administration
11.3.7.5.4 South Korea Oncology Small Molecule Drugs Market by Distribution Channel
11.3.7.6 Rest of Asia-Pacific Oncology Small Molecule Drugs Market
11.3.7.6.1 Rest of Asia-Pacific Oncology Small Molecule Drugs Market by Drug Class
11.3.7.6.2 Rest of Asia-Pacific Oncology Small Molecule Drugs Market by Indication Type
11.3.7.6.3 Rest of Asia-Pacific Oncology Small Molecule Drugs Market by Route of Administration
11.3.7.6.4 Rest of Asia-Pacific Oncology Small Molecule Drugs Market by Distribution Channel
11.4. MIDDLE EAST AND AFRICA
11.4.1 Middle East and Africa Oncology Small Molecule Drugs Market Overview
11.4.2 Middle East and Africa Oncology Small Molecule Drugs Market Forecasts and Analysis
11.4.3 Middle East and Africa Oncology Small Molecule Drugs Market Forecasts and Analysis - By Drug Class
11.4.4 Middle East and Africa Oncology Small Molecule Drugs Market Forecasts and Analysis - By Indication Type
11.4.5 Middle East and Africa Oncology Small Molecule Drugs Market Forecasts and Analysis - By Route of Administration
11.4.6 Middle East and Africa Oncology Small Molecule Drugs Market Forecasts and Analysis - By Distribution Channel
11.4.7 Middle East and Africa Oncology Small Molecule Drugs Market Forecasts and Analysis - By Countries
11.4.7.1 South Africa Oncology Small Molecule Drugs Market
11.4.7.1.1 South Africa Oncology Small Molecule Drugs Market by Drug Class
11.4.7.1.2 South Africa Oncology Small Molecule Drugs Market by Indication Type
11.4.7.1.3 South Africa Oncology Small Molecule Drugs Market by Route of Administration
11.4.7.1.4 South Africa Oncology Small Molecule Drugs Market by Distribution Channel
11.4.7.2 Saudi Arabia Oncology Small Molecule Drugs Market
11.4.7.2.1 Saudi Arabia Oncology Small Molecule Drugs Market by Drug Class
11.4.7.2.2 Saudi Arabia Oncology Small Molecule Drugs Market by Indication Type
11.4.7.2.3 Saudi Arabia Oncology Small Molecule Drugs Market by Route of Administration
11.4.7.2.4 Saudi Arabia Oncology Small Molecule Drugs Market by Distribution Channel
11.4.7.3 U.A.E Oncology Small Molecule Drugs Market
11.4.7.3.1 U.A.E Oncology Small Molecule Drugs Market by Drug Class
11.4.7.3.2 U.A.E Oncology Small Molecule Drugs Market by Indication Type
11.4.7.3.3 U.A.E Oncology Small Molecule Drugs Market by Route of Administration
11.4.7.3.4 U.A.E Oncology Small Molecule Drugs Market by Distribution Channel
11.4.7.4 Rest of Middle East and Africa Oncology Small Molecule Drugs Market
11.4.7.4.1 Rest of Middle East and Africa Oncology Small Molecule Drugs Market by Drug Class
11.4.7.4.2 Rest of Middle East and Africa Oncology Small Molecule Drugs Market by Indication Type
11.4.7.4.3 Rest of Middle East and Africa Oncology Small Molecule Drugs Market by Route of Administration
11.4.7.4.4 Rest of Middle East and Africa Oncology Small Molecule Drugs Market by Distribution Channel
11.5. SOUTH AND CENTRAL AMERICA
11.5.1 South and Central America Oncology Small Molecule Drugs Market Overview
11.5.2 South and Central America Oncology Small Molecule Drugs Market Forecasts and Analysis
11.5.3 South and Central America Oncology Small Molecule Drugs Market Forecasts and Analysis - By Drug Class
11.5.4 South and Central America Oncology Small Molecule Drugs Market Forecasts and Analysis - By Indication Type
11.5.5 South and Central America Oncology Small Molecule Drugs Market Forecasts and Analysis - By Route of Administration
11.5.6 South and Central America Oncology Small Molecule Drugs Market Forecasts and Analysis - By Distribution Channel
11.5.7 South and Central America Oncology Small Molecule Drugs Market Forecasts and Analysis - By Countries
11.5.7.1 Brazil Oncology Small Molecule Drugs Market
11.5.7.1.1 Brazil Oncology Small Molecule Drugs Market by Drug Class
11.5.7.1.2 Brazil Oncology Small Molecule Drugs Market by Indication Type
11.5.7.1.3 Brazil Oncology Small Molecule Drugs Market by Route of Administration
11.5.7.1.4 Brazil Oncology Small Molecule Drugs Market by Distribution Channel
11.5.7.2 Argentina Oncology Small Molecule Drugs Market
11.5.7.2.1 Argentina Oncology Small Molecule Drugs Market by Drug Class
11.5.7.2.2 Argentina Oncology Small Molecule Drugs Market by Indication Type
11.5.7.2.3 Argentina Oncology Small Molecule Drugs Market by Route of Administration
11.5.7.2.4 Argentina Oncology Small Molecule Drugs Market by Distribution Channel
11.5.7.3 Rest of South and Central America Oncology Small Molecule Drugs Market
11.5.7.3.1 Rest of South and Central America Oncology Small Molecule Drugs Market by Drug Class
11.5.7.3.2 Rest of South and Central America Oncology Small Molecule Drugs Market by Indication Type
11.5.7.3.3 Rest of South and Central America Oncology Small Molecule Drugs Market by Route of Administration
11.5.7.3.4 Rest of South and Central America Oncology Small Molecule Drugs Market by Distribution Channel
12. IMPACT OF COVID-19 PANDEMIC ON GLOBAL ONCOLOGY SMALL MOLECULE DRUGS MARKET
12.1 North America
12.2 Europe
12.3 Asia-Pacific
12.4 Middle East and Africa
12.5 South and Central America
13. INDUSTRY LANDSCAPE
13.1. MERGERS AND ACQUISITIONS
13.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
13.3. NEW PRODUCT LAUNCHES
13.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
14. ONCOLOGY SMALL MOLECULE DRUGS MARKET, KEY COMPANY PROFILES
14.1. JOHNSON AND JOHNSON
14.1.1. Key Facts
14.1.2. Business Description
14.1.3. Products and Services
14.1.4. Financial Overview
14.1.5. SWOT Analysis
14.1.6. Key Developments
14.2. BOEHRINGER INGELHEIM
14.2.1. Key Facts
14.2.2. Business Description
14.2.3. Products and Services
14.2.4. Financial Overview
14.2.5. SWOT Analysis
14.2.6. Key Developments
14.3. PFIZER
14.3.1. Key Facts
14.3.2. Business Description
14.3.3. Products and Services
14.3.4. Financial Overview
14.3.5. SWOT Analysis
14.3.6. Key Developments
14.4. MERCK
14.4.1. Key Facts
14.4.2. Business Description
14.4.3. Products and Services
14.4.4. Financial Overview
14.4.5. SWOT Analysis
14.4.6. Key Developments
14.5. GLAXOSMITHKLINE
14.5.1. Key Facts
14.5.2. Business Description
14.5.3. Products and Services
14.5.4. Financial Overview
14.5.5. SWOT Analysis
14.5.6. Key Developments
14.6. GILEAD SCIENCES
14.6.1. Key Facts
14.6.2. Business Description
14.6.3. Products and Services
14.6.4. Financial Overview
14.6.5. SWOT Analysis
14.6.6. Key Developments
14.7. TEVA PHARMACEUTICAL
14.7.1. Key Facts
14.7.2. Business Description
14.7.3. Products and Services
14.7.4. Financial Overview
14.7.5. SWOT Analysis
14.7.6. Key Developments
14.8. ALLERGAN
14.8.1. Key Facts
14.8.2. Business Description
14.8.3. Products and Services
14.8.4. Financial Overview
14.8.5. SWOT Analysis
The List of Companies

1. Johnson & Johnson
2. Boehringer Ingelheim
3. Pfizer
4. Merck
5. GlaxoSmithkline
6. Gilead Sciences
7. Teva Pharmaceutical
8. Allergan
9. Bristol- Myers Squibb
10. AstraZeneca.
TIPRE00021902
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing

Free

20%

customization on Pre-Booking